The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...
The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...
The U.S. Food and Drug Administration has labeled the broccoli recall as a Class I, the highest risk level issued by the ...
Following a recall of grounding pads produced by Megadyne, a machinery industry company, the FDA is notifying veterinarians ...
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible ...